AstraZeneca admits Covishield vaccine can cause rare blood clotting disorder TTS in "very rare cases."
TTS leads to formation of blood clots & low platelet count, potentially life-threatening complications.
Also watch
51 cases filed in UK court, victims seeking £100M in damages for injuries & deaths linked to vaccine.
Also watch
AstraZeneca facing legal battle over claims Covishield caused permanent brain injury, other severe effects.
Also watch
Pharmaceutical giant initially denied vaccine caused TTS, contradicting its latest admission in court.
Also watch
Victims' families urge apology, compensation from AstraZeneca for devastating impact of vaccine side effects.
Learn more
Regulatory bodies maintain Covishield benefits outweigh rare risks, emphasize vigilance & reporting crucial.
Learn more
Covishield played vital role in India's vaccination drive, but AstraZeneca's admission raises safety concerns.
Learn more
Legal proceedings to determine potential payouts, transparency & responsible communication key to public trust.
Learn more
Continued research & monitoring essential to ensure vaccine safety & address rare adverse events.
Learn more
Visit Us Now